Story

Blog

Get in Touch

Get in Touch
Tell us about your testing requirements

Story
Four leading laboratories that specialise in DNA testing, toxicology, gene copy number analysis, and more.

Simvastatin: More Than Just a Cholesterol-Lowering Medication

Published 02/05/2025

Back

A Close Look at Simvastatin

Simvastatin is one of the most widely prescribed statins in the UK, commonly used to lower cholesterol and reduce cardiovascular risk. But recent research shows that its benefits—and potential side effects—go far beyond cholesterol control. Understanding how simvastatin works, how it affects the body, and how genetic testing for medication response can influence its effects can empower patients to make more informed decisions about their treatment. This is where pharmacogenomics in the UK is becoming increasingly valuable, delivering results to patients and wider efficiencies to the NHS.

Introduction to Simvastatin

Simvastatin, like all statins, continues to surprise scientists and doctors—sometimes in positive ways, and sometimes in negative ones. Its positive "extras" are known as pleiotropic effects—beneficial actions that go beyond simply lowering cholesterol, such as improving blood vessel function or reducing inflammation (7). However, like other statins, simvastatin can also cause side effects, particularly muscle-related symptoms, which are an important consideration for patients and clinicians alike.

In both individual and meta-analytic studies, simvastatin has been shown to reduce sympathetic nervous system activity—the part of the nervous system that responds to stress—resulting in lower blood pressure (16, 17). While researchers are still investigating the clinical significance of this effect, it highlights the versatile, multi-system role statins can play in health.

Considerations for Patients Taking Simvastatin

When prescribing or taking simvastatin, it’s important to consider not only its cholesterol-lowering properties but also its broader impact on cardiovascular health—and the timing of when it’s taken. Like other statins, simvastatin has effects that extend well beyond lipid control, many of which contribute meaningfully to reducing the risk of heart attacks, strokes, and other cardiovascular events (2, 3, 4, 7).

Statins Do Much More Than Just Lower Cholesterol

Evidence shows that statins reduce mortality across a wide range of heart conditions—including heart failure—and can even reduce damage after a heart attack. Many of these benefits are independent of cholesterol lowering, thanks to the pleiotropic actions of statins.

These include (2, 3, 4, 7):

Stabilising cholesterol plaques (atherosclerotic plaques), making them less likely to rupture and cause blood clots.
Improving blood vessel function and reducing blood viscosity, enhancing circulation.
Anti-inflammatory effects, which are stronger in lipophilic statins like simvastatin compared to hydrophilic ones like rosuvastatin.

These diverse mechanisms highlight why personalised medicine for statins is an emerging area of interest.

The Body Makes More Cholesterol at Night

Cholesterol production in the liver follows a circadian rhythm—peaking between 8 p.m. and midnight (12). Taking statins like simvastatin at night can therefore optimise their cholesterol-lowering effects.

Why Simvastatin May Be Prescribed

Simvastatin may be prescribed for several reasons (5):

Elevated cholesterol that hasn't responded to diet and exercise
Primary prevention in individuals at high cardiovascular risk
Secondary prevention after heart attack or stroke (commonly used, though off-label in some regions)

How and When to Take Simvastatin

Simvastatin is typically taken once daily at night. Dosage varies based on the condition being treated and is usually adjusted every 4 weeks as needed (5):

10–20 mg for elevated cholesterol
40 mg, increasing up to 80 mg for familial hypercholesterolemia
20–40 mg, with a maximum of 80 mg, for cardiovascular event prevention

Patients using simvastatin in the UK should follow dosing advice closely and consider discussing PGx testing for statins with their healthcare provider.

Simvastatin Side Effects

Simvastatin is generally well tolerated, but it can cause side effects, especially at higher doses.

Muscle-related symptoms are the most common and include pain, soreness, or tenderness—especially in the thighs, calves, and hip flexors (6). These are the leading reason people stop taking statins and occur in 10–29% of patients.

Other possible side effects include:

Painful joints
Fatigue or low energy
Dizziness
Sleep disturbances
Liver problems
Memory issues (particularly at higher doses)

If you’re experiencing statin side effects, pharmacogenetic testing for statins may help identify whether your genes are playing a role.

Who Is at Risk of Side Effects?

Certain factors increase the risk of statin-related muscle symptoms (11):

Age over 60
Diabetes or hypothyroidism
Vitamin D deficiency
Strenuous exercise
Alcohol use
Major surgery
High statin doses (strongest risk factor)

Myasthenia gravis patients should also use statins cautiously, as symptoms may worsen (5).

How Genetics and Your Body Handle Simvastatin

Simvastatin’s journey through the body—absorption, distribution, metabolism, and elimination—is shaped by both biology and genetics (10).

Absorption: Taken up by the liver via a protein called OATP1B1, which is coded by the SLCO1B1 gene. This gene is a key focus in genetic testing for simvastatin response.
Metabolism: Extensively metabolised by liver enzymes CYP3A4 and CYP3A5. CYP2D6 polymorphisms may also influence efficacy and tolerance.

These insights highlight the value of pharmacogenomics UK services that assess how your body processes medications like statins.

Personalising Simvastatin with Pharmacogenetics

Genetic variation can affect how well simvastatin works and how likely it is to cause side effects. The gene SLCO1B1 plays a central role (10, 11):

Reduced function of OATP1B1 can raise drug levels in the bloodstream and increase muscle side effect risk.
The c.521T>C variant (rs4149056) is strongly associated with statin-induced myopathy.
People with two C alleles have a much higher risk of simvastatin- and lovastatin-induced muscle damage.

Other statins affected by similar genetic variations include atorvastatin, rosuvastatin, and pravastatin.

Could a Genetic Test Help?

Understanding your individual risk of side effects—especially from statins like simvastatin—can be challenging. A pharmacogenomics (PGx) test in the UK can help identify how your genes influence your response to medications like simvastatin, supporting safer, more personalised medicine through genetic testing for medication response.

References:

Explore PGx Testing